• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型生物瓣在绵羊模型中的体内重构潜力。

In vivo remodeling potential of a novel bioprosthetic tricuspid valve in an ovine model.

机构信息

CorMatrix Cardiovascular, Inc, Roswell, Ga.

Saint Joseph's Translational Research Institute, Atlanta, Ga.

出版信息

J Thorac Cardiovasc Surg. 2014 Jul;148(1):333-340.e1. doi: 10.1016/j.jtcvs.2013.10.048. Epub 2013 Dec 19.

DOI:10.1016/j.jtcvs.2013.10.048
PMID:24360254
Abstract

OBJECTIVES

A novel bioprosthetic tricuspid valve was constructed from an acellular extracellular matrix (ECM) bioscaffold. The valve's mechanical functionality and potential for histologic regeneration was evaluated in an ovine model.

METHODS

The native tricuspid valves of 4 domestic sheep were excised and replaced with bioprosthetic valves constructed from the ECM bioscaffold material shaped into the form of a tube. In vivo function was assessed over time by transthoracic echocardiography. Animals were euthanized at 3, 5, 8, and 12 months after valve implantation, and explanted valves were examined for gross morphology and by qualitative histopathologic analysis.

RESULTS

All 4 sheep survived until the specified date. Forward flow by echocardiography was normal with trivial to mild regurgitation. Annular morphology and mobility of the leaflets appeared normal with excellent leaflet coaptation. Explanted valves were grossly normal at all time points and showed evidence of progressive tissue remodeling and integration at the host-tissue interface. Histopathologic analysis demonstrated massive host-cell infiltration, structural reorganization of the ECM bioscaffold, elastin generation at the annulus by 3 months, and increased collagen organization and glycosaminoglycan presence in the leaflets by 5 months, with no evidence of foreign body response.

CONCLUSIONS

When implanted in the form of a tubular valve, the acellular ECM bioscaffold demonstrates feasibility as a biomechanically sound bioprosthetic tricuspid valve replacement with evidence of progressive endothelialization and constructive tissue remodeling.

摘要

目的

我们构建了一种新型的无细胞细胞外基质(ECM)生物支架瓣叶,用于构建生物假体三尖瓣。我们评估了该瓣膜在绵羊模型中的机械功能和组织再生潜力。

方法

我们从 4 只绵羊的原生三尖瓣中取出瓣膜,并将其替换为 ECM 生物支架材料制成的管状生物假体瓣膜。通过经胸超声心动图评估体内功能随时间的变化。在瓣膜植入后 3、5、8 和 12 个月,对动物进行安乐死,并对植入的瓣膜进行大体形态和定性组织病理学分析。

结果

所有 4 只绵羊均存活至指定日期。超声心动图显示前向血流正常,仅有轻微至轻度反流。瓣环形态和瓣叶活动度正常,瓣叶对合良好。在所有时间点,植入的瓣膜大体上均正常,在宿主组织界面处显示出进行性组织重塑和整合的迹象。组织病理学分析显示大量宿主细胞浸润,ECM 生物支架的结构重排,3 个月时在瓣环处生成弹性蛋白,5 个月时瓣叶中胶原蛋白组织增加和糖胺聚糖存在,无异物反应证据。

结论

以管状瓣膜的形式植入时,无细胞 ECM 生物支架具有作为机械性能良好的生物假体三尖瓣置换物的可行性,具有进行性内皮化和建设性组织重塑的证据。

相似文献

1
In vivo remodeling potential of a novel bioprosthetic tricuspid valve in an ovine model.新型生物瓣在绵羊模型中的体内重构潜力。
J Thorac Cardiovasc Surg. 2014 Jul;148(1):333-340.e1. doi: 10.1016/j.jtcvs.2013.10.048. Epub 2013 Dec 19.
2
Physiological Growth, Remodeling Potential, and Preserved Function of a Novel Bioprosthetic Tricuspid Valve: Tubular Bioprosthesis Made of Small Intestinal Submucosa-Derived Extracellular Matrix.新型生物三尖瓣的生理生长、重塑潜能和功能保留:源自小肠黏膜下衍生细胞外基质的管状生物瓣。
J Am Coll Cardiol. 2015 Aug 25;66(8):877-88. doi: 10.1016/j.jacc.2015.06.1091.
3
Transvenous, antegrade Melody valve-in-valve implantation for bioprosthetic mitral and tricuspid valve dysfunction: a case series in children and adults.经静脉、顺行 Melody 瓣中瓣植入治疗生物瓣二尖瓣和三尖瓣功能障碍:一项儿童和成人病例系列研究。
JACC Cardiovasc Interv. 2013 Jun;6(6):598-605. doi: 10.1016/j.jcin.2013.02.010. Epub 2013 May 15.
4
Mid-term function and remodeling potential of tissue engineered tricuspid valve: Histology and biomechanics.组织工程三尖瓣的中期功能及重塑潜力:组织学与生物力学
J Biomech. 2018 Apr 11;71:52-58. doi: 10.1016/j.jbiomech.2018.01.019. Epub 2018 Feb 2.
5
Papillary muscle force distribution after total tricuspid reconstruction using porcine extracellular matrix: in-vitro valve characterization.使用猪细胞外基质进行全三尖瓣重建后的乳头肌力分布:体外瓣膜特性分析
J Heart Valve Dis. 2014 Nov;23(6):788-94.
6
Transcatheter treatment of tricuspid regurgitation by caval valve implantation--experimental evaluation of decellularized tissue valves in central venous position.通过腔静脉瓣膜植入进行经导管三尖瓣反流治疗——中心静脉位置去细胞组织瓣膜的实验评估
Catheter Cardiovasc Interv. 2015 Jan 1;85(1):150-60. doi: 10.1002/ccd.25380. Epub 2014 Feb 1.
7
Early percutaneous valve failure within bioprosthetic tricuspid tissue valve replacements.生物瓣三叶式组织心脏瓣膜置换术后早期经皮瓣失效。
Catheter Cardiovasc Interv. 2013 Sep 1;82(3):428-35. doi: 10.1002/ccd.24622. Epub 2013 Mar 14.
8
Clinical and echocardiographic outcomes after surgery for severe isolated tricuspid regurgitation.严重孤立性三尖瓣反流患者手术后的临床和超声心动图结果。
J Thorac Cardiovasc Surg. 2013 Aug;146(2):278-84. doi: 10.1016/j.jtcvs.2012.04.019. Epub 2012 Aug 4.
9
An integrated pericardial valved stent special for percutaneous tricuspid implantation: an animal feasibility study.经皮三尖瓣植入用一体式带瓣心包支架的动物可行性研究。
J Surg Res. 2010 May 15;160(2):215-21. doi: 10.1016/j.jss.2008.10.029. Epub 2008 Nov 29.
10
A randomized assessment of an advanced tissue preservation technology in the juvenile sheep model.一种先进的组织保存技术在幼年绵羊模型中的随机评估。
J Thorac Cardiovasc Surg. 2015 Jan;149(1):340-5. doi: 10.1016/j.jtcvs.2014.09.062. Epub 2014 Sep 28.

引用本文的文献

1
Tissue response and clinical outcomes after cardiovascular use of porcine small intestinal small intestinal submucosal extracellular matrix: a systematic review.猪小肠黏膜下层细胞外基质用于心血管疾病后的组织反应及临床结果:一项系统评价
Front Cardiovasc Med. 2025 Jun 25;12:1532157. doi: 10.3389/fcvm.2025.1532157. eCollection 2025.
2
Cardiovascular patches applied in congenital cardiac surgery: Current materials and prospects.先天性心脏手术中应用的心血管补片:当前材料与前景
Bioeng Transl Med. 2024 Sep 30;10(1):e10706. doi: 10.1002/btm2.10706. eCollection 2025 Jan.
3
Physician antibiotic hydration preferences for biologic antibacterial envelopes during cardiac implantable device procedures.
心脏植入式设备手术期间医生对生物抗菌包膜的抗生素水化偏好。
Front Cardiovasc Med. 2022 Dec 22;9:1006091. doi: 10.3389/fcvm.2022.1006091. eCollection 2022.
4
In vivo efficacy of a polymer layered decellularized matrix composite as a cell honing cardiovascular tissue substitute.聚合物分层脱细胞基质复合材料作为细胞优化心血管组织替代物的体内疗效
Mater Today Bio. 2022 Oct 23;17:100451. doi: 10.1016/j.mtbio.2022.100451. eCollection 2022 Dec 15.
5
Can Heart Valve Decellularization Be Standardized? A Review of the Parameters Used for the Quality Control of Decellularization Processes.心脏瓣膜脱细胞处理能否实现标准化?脱细胞处理过程质量控制参数综述。
Front Bioeng Biotechnol. 2022 Feb 17;10:830899. doi: 10.3389/fbioe.2022.830899. eCollection 2022.
6
Pathological Changes of Adult Mitral Valves after Failed CorMatrix ECM Repair.CorMatrix ECM修复失败后成人二尖瓣的病理变化
J Clin Transl Pathol. 2021;1(1):9-15. doi: 10.14218/jctp.2021.00009. Epub 2021 Aug 24.
7
Antibiotic-Eluting Envelopes to Prevent Cardiac-Implantable Electronic Device Infection: Past, Present, and Future.抗生素洗脱封套预防心脏植入式电子设备感染:过去、现在与未来
Cureus. 2021 Feb 2;13(2):e13088. doi: 10.7759/cureus.13088.
8
Next-generation tissue-engineered heart valves with repair, remodelling and regeneration capacity.具有修复、重塑和再生能力的下一代组织工程心脏瓣膜。
Nat Rev Cardiol. 2021 Feb;18(2):92-116. doi: 10.1038/s41569-020-0422-8. Epub 2020 Sep 9.
9
Mitral Valve Replacement in Pediatrics Using an Extracellular Matrix Cylinder Valve: A Case Series.儿科应用细胞外基质圆柱瓣行二尖瓣置换术:病例系列研究。
Pediatr Cardiol. 2020 Oct;41(7):1458-1465. doi: 10.1007/s00246-020-02382-3. Epub 2020 Jun 30.
10
Preclinical evaluation of efficacy and pharmacokinetics of gentamicin containing extracellular-matrix envelope.含细胞外基质包膜的庆大霉素的药效学和药代动力学的临床前评价。
Pacing Clin Electrophysiol. 2020 Mar;43(3):341-349. doi: 10.1111/pace.13888. Epub 2020 Mar 5.